Page 1 of 5
- Toll Free: +1-800-792-5285
- (UK): +44-845-528-1300
- Int'l: +1-503-894-6022
- Help@alliedmarketresearch.com
Cart
Reports by Allied Market Research furnish an in-depth analysis of market structure for diagnostics and biotech business. Segmented study of industry verticals has been reported in a comprehensive format to highlight growth drivers and restraints. Moreover, leading company profiles have been assessed for their market capture and business offerings, along with profit earnings.
Page 1 of 5
The Global Refurbished DNA Sequencing Platforms Market was valued at $41 million in 2016 and is expected to reach $112 million in 2023, registering a CAGR of 15.0% from 2017 to 2023. DNA sequencing is a technology in which several ...
The global culture media market was valued at $3,775 million in 2016, and is estimated to reach at $6,532 million by 2023, registering a CAGR of 8.1% from 2017 to 2023. Culture media is used in microbiological laboratories and research ...
The Global Transcriptomics Market was valued at $3,130 million in 2016, and is projected to reach $4,658 million by 2023, growing at a CAGR of 5.8% during the study period. Transcriptomics is the study of entire set of RNA transcripts ...
The global womens health diagnostics market was valued at $13,133 million in 2016, and is projected to reach $21,501 million at a CAGR of 7.0% from 2017 to 2023. Women are more prone to certain diseases, mostly related to menstrual ...
The global viral vector and plasmid DNA manufacturing market accounted for $261 million in 2016, and is expected to reach $1090 million by 2023, registering a CAGR of 22.6% from 2017 to 2023. Viral vectors and plasmid DNA manufacturing commonly ...
The Hospital-acquired Infection Diagnostics Market was valued at $2,571 million in 2016, and is expected to reach at $4,311 million by 2023. It is anticipated to register a CAGR of 7.5% during the period, 2017“2023. Hospital-acquired infections are the infections ...
PET-CT Scanner Device Market accounted for $1,454 million in 2016, and is estimated to reach $2,108 million by 2023, growing at a CAGR of 5% during the analysis period (2017“2023). There is a high prevalence of diseases worldwide, hence an increase in the need of diagnosis.
Cell-based Assay Market was valued at $3,625 million in 2016, and is expected to reach $10,618 million in 2023, registering a CAGR of 16.5% from 2017 to 2023. Cell-based assays encompass a variety of assays that measure cellular parameters such as cell toxicity, proliferation, production of markers, activation of specific signaling pathways, motility, and changes in morphology.
The Europe IVD market is accounted for $19,124 million in 2016, and is estimated to reach $26,623 million by 2023, growing at a CAGR of 4.7% during the analysis period (2017“2022). IVD diagnostics involve non-invasive tests performed on biological samples ...
Global Metabolomics Market was valued at $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023. Metabolomics is the study and analysis of the biochemical processes involving intermediates ...
Global Medical Imaging Reagents Market was valued at $10,772 million in 2016, and is estimated to reach $18,587 million by 2023, registering a CAGR of 8.0% from 2017 to 2023. Medical imaging reagents are chemicals used to visualize organs or ...
The France IVD market accounted for $2,943 million in 2016, and is estimated to reach $4,509 million by 2023, growing at a CAGR of 6.2% during the forecast period (2017-2023). In vitro diagnostics is a medical procedure employed to detect ...
UK IVD market is accounted for $2,148 million in 2016, and is estimated to reach $3,127 million by 2023, growing at a CAGR of 5.4% during the analysis period (2017-2023). In vitro diagnostics are the medical devices, which are utilized ...
Global Drug Screening Market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7%, during the forecast period, 20172023. Drug screening test analyses biological samples, such as blood, hair, & urine; to ...
tattoo removal market was valued at $11,614 million in 2016, and is projected to reach at $27,317 million by 2023, growing at a CAGR of 12.7% from 2017 to 2023. Tattoo is defined as the temporary or permanent mark made ...
Global Cancer/tumor Profiling Market was valued at $25,318 million in 2016, and is expected to reach $82,447 million by 2023, registering a CAGR of 18.4% from 2017 to 2023. Cancer/tumor profiling provides information about the genes causing cancer, which would ...
global mass spectrometry market was valued at $4,598 million in 2016, and is estimated to reach at $7,922 million by 2023, registering a CAGR of 8.0% from 2017 to 2023. Mass spectrometry is an analytical technique used to determine and ...
Global Cord Blood Banking Services Market was valued at $1,126 million in 2016, and is estimated to reach at $2,772 million by 2023, registering a CAGR of 13.8% from 2017 to 2023. Cord blood contains a rich source of stem ...
The Global Single-use Bioprocessing (Sub) Market was valued at $2,800 million in 2016, and is expected to reach $9,342 million by 2023, registering a CAGR of 18.7% from 2017 to 2023. Single-use bioprocessing employs disposable technologies for the development and ...
The Precision Medicine Market was valued at $3,516 million in 2016, and is estimated to reach at $7,746 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. Precision medicine is based on a unique concept that states, ...
The Global Epigenetics Market was valued at $555 million in 2016, and is estimated to reach at $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023. Epigenetics is an extension of genetics and developmental biology, which ...
The global blood market was valued at $33,500 million in 2016, and is estimated to reach $45,982 million by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Blood market involves the selling of whole blood & blood ...
Global Nerve Repair and Regeneration Market was valued at $5,927 million in 2016, and is estimated to reach $13,938 million by 2023, growing at a CAGR of 13.0% from 2017 to 2023. The complex, delicate structures that make up the ...
The global DNA sequencing market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in which several DNA strands ...
The global early toxicity testing market was $614 million and is estimated to reach $1,012 million by 2022, registering a CAGR of 7.3% from 2016 to 2022. Toxins are substances that can adversely affect living organisms. They are present in ...
Global Molecular Diagnostics Market was valued at $5,962 million in 2016, and is expected to garner $10,557 million by 2023, registering a CAGR of 9.1% during the forecast period 2017-2023. Molecular diagnostic tests are used to detect specific sequences in DNA or RNA, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, and others to further diagnose the disease.
The global blood gas and electrolyte analyzers market was valued at $1,427 million in 2016, and is estimated to reach $2,104 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023. Blood gas and electrolyte analyzers are ...
The global liquid biopsy market was valued at $634 million in 2016, and is estimated to reach at $3,805 million by 2023, registering a CAGR of 28.9% from 2017 to 2023. Liquid biopsy tests are executed to understand the molecular ...
miRNA Tools and Services Market was valued at $146 million in 2015 and is expected to garner $620 million by 2022, registering a CAGR of 23.4% during the forecast period 2016 - 2022.
The global medical videoscopes market consists of videoscopes and visualization systems, and has witnessed significant technological advancements.
The Arthroscopy Devices Market is estimated to reach $5,334 million from $3,453 million and grow at a CAGR of 6.2% by 2022. An arthroscope is a medical device used to visualize, examine, and execute therapeutic interventions inside the joints of the body, such as knee, hip, spine, shoulder, elbow, and others.
The global animal therapeutics and diagnostics market was valued at $23,793 million in 2015, and is projected to reach $36,226 million by 2022, growing at a CAGR of 6.1% from 2016 to 2022. Diagnostic instruments aid in the determination of ...
The global photomedicine market was valued at $2,750 million in 2015, and is projected to reach $5,511 million by 2022, growing at a CAGR of 10.3% from 2016 to 2022. In photomedicine, light is emitted at specific frequencies with the ...
The Asia Pacific in vitro fertilisation market, valued at $3.0 billion in 2015, is estimated to reach $7.1 billion by 2022, growing at a CAGR of 13.3% during the forecast period. The Asia-Pacific in vitro fertilisation market is the fastest ...
The global IVTT market size is estimated to be $2,921 million in 2015 and is expected to reach $7,813 million registering a CAGR of 15.07% from 2016 to 2022. In vitro is the process that helps examine harmful chemicals over ...
The global PGD market size is estimated to be $79 million in 2015 and expected to reach $121 million registering a CAGR of 6.14% from 2016 to 2022. Preimplantation genetic diagnosis (PGD) also referred as embryo screening, is a branch ...
The global endoscopy devices market is anticipated to grow at a CAGR of 5.7% from 2016 to 2022, and reach $40,854 million by 2022 from $27,273 in 2015. An endoscope is a lighted, medical device used to execute diagnostic and ...
Global Cancer biomarkers market size is $15,737 million by 2022, registering a CAGR of 13.3% from 2016 to 2022. Cancer biomarkers are molecules released during the presence of a tumor or a particular indication in the body to the presence of cancer.
Protein labeling is process used in biological research which makes use of molecular labels to covalently bond to the protein of interest. This helps in the detection and purification of the labeled protein and/or its binding associates. Protein labeling can ...
The Global immunodiagnostics market is projected to grow at a CAGR of 7.3% from 2016 to 2022. Immunodiagnostics is the branch of in vitro diagnostics that deals with the diagnosis of several diseases on the basis of antigen antibody reaction. ...
Exosome Diagnostic and Therapeutic Market was valued at $39 million, and is expected to reach $368 million by 2022, supported by a CAGR of 37.8%. Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses ...
Advanced Wound Care Market (AWC Market) was valued at $7,117 million, and is expected to reach $12,454 million by 2022, supported by a CAGR of 8.3%. Advanced wound care products and traditional wound care products are used to treat acute ...
The global flow cytometry market is estimated to reach $7 billion by 2022, registering a CAGR of 16.0% over the forecast period 2014“2022.
Medical/diagnostic imaging market is expected to reach $45 billion by 2022, growing at a CAGR of 5.1% during the forecast period 2015 - 2022. Medical/Diagnostic Imaging refers to the use of different imaging modalities to get visual representations of the ...
Global synthetic biology market size was valued at $5,245.7 million in 2015, registering a CAGR of 15.5% during the forecast period 2015 - 2022. Synthetic biology is a novel area of research that is the amalgamation of multiple disciplines such as molecular biology, biotechnology, biophysics and genetic engineering among others.
Flow cytometry is a laser based, biophysical technology that is utilized in the analysis of several physical parameters cells when suspended in a heterogeneous fluid mixture. The flow cytometry technology possesses more precision and accuracy, and lesser time consumption as ...
Enzymes Market is Expected to Reach $5.4 Billion, Worldwide, by 2020, to register a CAGR of 7.8% during 2015-2020 with several key players exploring new regions. Enzymes have gathered a special attention in the recent years due to its potential ...
Global Cardiac Biomarkers Market is expected to garner $2,085.9 million by 2020, registering a CAGR of 18.9% during the forecast period 2015-2020. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.
Specialty enzymes have gained popularity in the recent years owing to their potential applications in various industries such as pharmaceutical, biotechnology research and diagnostics. Specialty enzymes are proteins that act as biocatalysts to accelerate reactions and produce the desired results in pharmaceuticals and diagnostics reactions.
Global syphilis testing market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the forecast period 2014-2020. Syphilis is one of the vital sexually transmitted infections (STIs) caused by the bacteria named, Treponema pallidum, and can lead to long-term complications, if not diagnosed adequately.
Page 1 of 5
To ensure high level data integrity, accurate analysis and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
